Literature DB >> 27105050

Brief Report: Seroprevalence of Pertussis Infection in HIV-Infected Adults in the United States.

Stephanie B Troy1, Alexandria E-B Rossheim, DaShaunda D Hilliard, Tina D Cunningham.   

Abstract

Pertussis is a resurgent infection that can cause significant morbidity among adults. CD4 T cells are necessary for its clearance, but pertussis studies in HIV-infected adults are limited to case reports. We analyzed stored serum samples from 299 HIV-infected adults to determine the seroprevalence of pertussis among this population. We found that 4.3% of subjects had serologic evidence of recent pertussis infection, and annual incidence of pertussis infection among subjects not vaccinated against pertussis in the last 5 years was 10.5%-17.5%. Prospective studies are needed to define the clinical presentation of pertussis in HIV-infected adults and to optimize vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27105050      PMCID: PMC5065371          DOI: 10.1097/QAI.0000000000001037

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  24 in total

1.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?

Authors:  Lucia C Pawloski; Kathryn B Kirkland; Andrew L Baughman; Monte D Martin; Elizabeth A Talbot; Nancy E Messonnier; Maria Lucia Tondella
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

3.  Seroprevalence of pertussis in China: need to improve vaccination strategies.

Authors:  Yinghua Xu; Lichan Wang; Jin Xu; Xinjian Wang; Chen Wei; Peng Luo; Xiao Ma; Qiming Hou; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

4.  Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

Authors:  Joel I Ward; James D Cherry; Swei-Ju Chang; Susan Partridge; Wendy Keitel; Kathryn Edwards; Martin Lee; John Treanor; David P Greenberg; Stephen Barenkamp; David I Bernstein; Robert Edelman
Journal:  Clin Infect Dis       Date:  2006-06-05       Impact factor: 9.079

5.  Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

Authors:  P Strebel; J Nordin; K Edwards; J Hunt; J Besser; S Burns; G Amundson; A Baughman; W Wattigney
Journal:  J Infect Dis       Date:  2001-03-30       Impact factor: 5.226

6.  Waning protection after fifth dose of acellular pertussis vaccine in children.

Authors:  Nicola P Klein; Joan Bartlett; Ali Rowhani-Rahbar; Bruce Fireman; Roger Baxter
Journal:  N Engl J Med       Date:  2012-09-13       Impact factor: 91.245

7.  The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.

Authors:  Qi Zhang; Huizhen Zheng; Meizhen Liu; Ke Han; Jun Shu; Chenggang Wu; Ning Xu; Qiushui He; Huiming Luo
Journal:  BMC Infect Dis       Date:  2012-06-20       Impact factor: 3.090

8.  Pertussis in an adult man infected with the human immunodeficiency virus.

Authors:  B N Doebbeling; M L Feilmeier; L A Herwaldt
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

9.  Efficacy of an acellular pertussis vaccine among adolescents and adults.

Authors:  Joel I Ward; James D Cherry; Swei-Ju Chang; Susan Partridge; Hang Lee; John Treanor; David P Greenberg; Wendy Keitel; Stephen Barenkamp; David I Bernstein; Robert Edelman; Kathryn Edwards
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

10.  Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

Authors:  Mark J Abzug; Lin-Ye Song; Terence Fenton; Sharon A Nachman; Myron J Levin; Howard M Rosenblatt; Stephen I Pelton; William Borkowsky; Kathryn M Edwards; Jody Peters
Journal:  Pediatrics       Date:  2007-10-15       Impact factor: 7.124

View more
  2 in total

1.  Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project.

Authors:  Rulin C Hechter; Lei Qian; Sara Y Tartof; Lina S Sy; Nicola P Klein; Eric Weintraub; Cheryl Mercado; Allison Naleway; Huong Q McLean; Steven J Jacobsen
Journal:  Vaccine       Date:  2019-05-04       Impact factor: 3.641

2.  Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.

Authors:  Alessandra Ruggiero; Giuseppe Rubens Pascucci; Nicola Cotugno; Sara Domínguez-Rodríguez; Stefano Rinaldi; Alfredo Tagarro; Pablo Rojo; Caroline Foster; Alasdair Bamford; Anita De Rossi; Eleni Nastouli; Nigel Klein; Elena Morrocchi; Benoit Fatou; Kinga K Smolen; Al Ozonoff; Michela Di Pastena; Katherine Luzuriaga; Hanno Steen; Carlo Giaquinto; Philip Goulder; Paolo Rossi; Ofer Levy; Savita Pahwa; Paolo Palma
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.